drugset / Trial / NCT01570660

Phielix et al.: Hepatic Fat Content and Adipokines

NCT01570660

Completed 24 enrolled German Diabetes Center
NaSingle-groupOpen-labelBasic science

Summary

Thiazoledinediones decrease blood glucose by their insulin-sensitizing properties. Here the investigators examined whether pioglitazone (PIO) improves insulin sensitivity independently of glycemic control and whether adipokines or non-esterfied fatty acids (NEFA) serve as mediators.

Timeline

Start
2002-02
Primary completion
2012-03
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pioglitazone Small molecule 30 mg